LOS ANGELES--(BUSINESS WIRE)--Response Genetics Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests for cancer, announced today that Denise McNairn, interim CEO, vice president, general counsel and secretary, David O’Toole, chief financial officer, and Chris Meda, president, will present at 2011 UBS Global Life Sciences Conference at the Grand Hyatt in New York.
